☰

Todd P. Knutson, Ph.D. - Publications

Affiliations: 
2012 Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Genetics, Endocrinology Biology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forster CL, et al. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology. PMID 37186300 DOI: 10.1002/path.6082  0.692
2020 Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, Schwertfeger KL. Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. 2020, , 1325. Cancers. 12. PMID 32977674 DOI: 10.3390/cancers12102736  0.305
2020 Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, Munro SA, Tiegs L, McCarthy JB, Nelson AC, Schwertfeger KL. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers. 12. PMID 32455980 DOI: 10.3390/Cancers12051325  0.496
2020 Daughters CE, Knutson TP, Forster C, McCarthy J, Schwertfeger K, Nelson A. Abstract 2731: Receptor for Hyaluronan Mediated Motility (RHAMM) promotes breast cancer progression Tumor Biology. DOI: 10.1158/1538-7445.Am2020-2731  0.584
2019 Irey EA, Lassiter CM, Brady NJ, Chuntova P, Wang Y, Knutson TP, Henzler C, Chaffee TS, Vogel RI, Nelson AC, Farrar MA, Schwertfeger KL. JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proceedings of the National Academy of Sciences of the United States of America. PMID 31147469 DOI: 10.1073/Pnas.1816410116  0.361
2019 Ahmed RL, Shaughnessy DP, Knutson TP, Vogel RI, Ahmed K, Kren BT, Trembley JH. CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells. Pharmaceuticals (Basel, Switzerland). 12. PMID 30987032 DOI: 10.3390/Ph12020050  0.424
2017 Knutson TP, Truong TH, Ma S, Brady NJ, Sullivan ME, Raj G, Schwertfeger KL, Lange CA. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. Journal of Hematology & Oncology. 10: 89. PMID 28412963 DOI: 10.1186/S13045-017-0462-7  0.737
2016 Girard BJ, Knutson TP, Kuker B, McDowell L, Schwertfeger KL, Ostrander JH. Cytoplasmic Localization of Proline, Glutamic Acid, Leucine Rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Upregulation of Inhibitor of kappa B Kinase Epsilon and Inflammatory Crosstalk with Macrophages. The Journal of Biological Chemistry. PMID 27881676 DOI: 10.1074/Jbc.M116.739847  0.549
2016 Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, Krutilina R, Seagroves TN, Lange CA. Breast Tumor Kinase (Brk/PTK6) is Induced by HIF, Glucocorticoid Receptor and PELP1 Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Research. PMID 26825173 DOI: 10.1158/0008-5472.Can-15-2510  0.695
2016 Diep CH, Knutson TP, Mauro LJ, Lange CA. Abstract A39: FOXO1 is a key determinant of progesterone receptor isoform-specific senescence programming in ovarian cancer cells. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A39  0.728
2015 Diep CH, Knutson TP, Lange CA. Active FOXO1 is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research : McR. PMID 26577046 DOI: 10.1158/1541-7786.Mcr-15-0431  0.721
2015 Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA. Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology. 54: R31-53. PMID 25587053 DOI: 10.1530/Jme-14-0252  0.721
2015 Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D'Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA. Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. 34: 506-15. PMID 24469035 DOI: 10.1038/Onc.2013.579  0.745
2015 Ostrander JH, Girard BJ, Knutson T, Kuker B, Seewaldt V. Abstract P4-05-03: Cytoplasmic PELP1 promotes breast cancer initiation via NF-κB signaling Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-05-03  0.612
2015 Hagan CR, Knutson TP, Lange CA. Abstract 1868A: Progesterone receptor promotes inflammatory gene programs in breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-1868A  0.744
2014 Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 28: 442-57. PMID 24606123 DOI: 10.1210/Me.2013-1196  0.713
2014 Knutson TP, Lange CA. Tracking progesterone receptor-mediated actions in breast cancer. Pharmacology & Therapeutics. 142: 114-25. PMID 24291072 DOI: 10.1016/J.Pharmthera.2013.11.010  0.758
2013 Hagan CR, Knutson TP, Lange CA. A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research. 41: 8926-42. PMID 23921636 DOI: 10.1093/Nar/Gkt706  0.686
2013 Knutson TP, Lange CA. Dynamic regulation of steroid hormone receptor transcriptional activity by reversible SUMOylation. Vitamins and Hormones. 93: 227-61. PMID 23810010 DOI: 10.1016/B978-0-12-416673-8.00008-3  0.622
2013 Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, Yee D, Lange CA. Abstract 3572: Unliganded progesterone receptors augment estrogen-induced growth of breast cancer cells via co-regulation of estrogen receptor target genes. Cancer Research. 73: 3572-3572. DOI: 10.1158/1538-7445.Am2013-3572  0.742
2013 Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA. Abstract 3569: Phosphorylated and SUMO-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Cancer Research. 73: 3569-3569. DOI: 10.1158/1538-7445.Am2013-3569  0.771
2012 Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Research : Bcr. 14: R95. PMID 22697792 DOI: 10.1186/Bcr3211  0.743
2012 Diaz J, Aranda E, Henriquez S, Quezada M, Espinoza E, Bravo ML, Oliva B, Lange S, Villalon M, Jones M, Brosens JJ, Kato S, Cuello MA, Knutson TP, Lange CA, et al. Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. The Journal of Endocrinology. 214: 165-75. PMID 22593082 DOI: 10.1530/Joe-11-0310  0.741
2011 Knutson TP, Daniel AR, Lange CA. Abstract 3102: Phosphorylated and SUMO-deficient progesterone receptors transcriptionally up-regulate growth factor signaling pathway genes in breast cancer cells Cancer Research. 71: 3102-3102. DOI: 10.1158/1538-7445.Am2011-3102  0.763
2009 Daniel AR, Knutson TP, Lange CA. Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Molecular and Cellular Endocrinology. 308: 47-52. PMID 19549591 DOI: 10.1016/J.Mce.2009.01.004  0.695
2009 Rahrmann EP, Collier LS, Knutson TP, Doyal ME, Kuslak SL, Green LE, Malinowski RL, Roethe L, Akagi K, Waknitz M, Huang W, Largaespada DA, Marker PC. Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Research. 69: 4388-97. PMID 19401450 DOI: 10.1158/0008-5472.Can-08-3901  0.342
2009 Dressing GE, Hagan CR, Knutson TP, Daniel AR, Lange CA. Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models. Endocrine-Related Cancer. 16: 351-61. PMID 19357196 DOI: 10.1677/Erc-08-0281  0.697
Show low-probability matches.